FDA approves Abbott Labs' Humira for juvenile arthritis

02/25/2008 | Yahoo!

Humira, Abbott Laboratories' injectable drug, has obtained FDA clearance to treat moderate-to-severe juvenile idiopathic arthritis in patients aged 4 years and older. The drug, which is administered every two weeks, is the first biological treatment for the disease to obtain approval since 1999, Abbot said. Humira is already approved for the treatment of rheumatoid arthritis and other conditions in adults.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY